Cite Filings / FULC / 0001193125-19-204925
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
SC 13G

Amended Statement of Ownership

Fulcrum Therapeutics, Inc. · Filed 2019-07-29 · Acc 0001193125-19-204925

Documents 1

  • SC 13G Amended Statement of Ownership , d785220dsc13g.htm

Around this filing

  • 2020-02-05 SC 13G Amended Statement of Ownership
  • 2019-07-29 SC 13G Amended Statement of Ownership
  • 2019-07-29 SC 13G Amended Statement of Ownership
  • 2019-07-24 4 10% owner acquired 1,785,714 shares (conversion)
  • 2019-07-23 4 10% owner bought 93,750 shares at $16.00 ($1,500,000)
  • 2019-07-22 4 10% owner bought 140,000 shares at an average $15.84 ($2,217,495)
  • 2019-07-22 8-K Bylaws or fiscal year change

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)

Stakes reported in this filing

Stake history · largest stake in each 13D and 13G

  1. 2026-11-16 SCHEDULE 13G · ADAR1 Capital Management, LLC 8.7%
  2. 2026-11-16 SCHEDULE 13G/A · EcoR1 Capital, LLC 8.9%
  3. 2026-11-13 SCHEDULE 13G/A · Nantahala Capital Management, LLC 8.62%
  4. 2026-11-13 SCHEDULE 13G/A · Montanova Capital, LLC 0%
Loading d785220dsc13g.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…